FDA warns Genentech clinical investigator working on preventive flu antiviral trial

The FDA on Tuesday released a warning letter that it sent to a clinical investigator involved in Genentech’s Phase IIIb trial for the antiviral Xofluza (baloxavir marboxil) for reducing flu transmission from otherwise healthy patients to household contacts.

The regulator said the investigator — Melanie Hoppers, co-founder and chief medical…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks